COMPANY INFO
Outset, officially known as Outset.ai, is a software development company founded in 2022 by Aaron Cannon (co-founder and CEO), Molly Montgomery, and Michael Hess. It is headquartered in San Francisco, CA, and operates in the business/productivity software industry, specializing in AI-moderated research platforms that enable companies to conduct in-depth qualitative research at scale with AI-powered interviews and analytics. The company has about 11 to 12 employees and serves major enterprises like WeightWatchers, Nestle, and Microsoft, helping them gain deep customer insights quickly and efficiently through AI-driven interviews and usability testing.
Outset Medical, Inc. is a leading personal products company based in San Jose, California, specializing in the design, development, and manufacture of innovative medical devices for dialysis care. Outset Medical is best known for its Tablo hemodialysis system, which is improving the accessibility, efficiency, and effectiveness of acute and home dialysis treatment for patients and healthcare providers worldwide.
The Outset Medical, Inc. leadership team brings together deep expertise across medical technology, clinical operations, financial management, and technology innovation. With senior leaders experienced in scaling medtech companies, developing next-generation products, and executing on global go-to-market strategies, the Outset Medical executives have positioned the company for continued growth and sector leadership. Their backgrounds span Fortune 500 healthcare, VC-backed startups, and global finance, directly contributing to the company’s rapid advancement and reputation for operational excellence.
Leslie Trigg serves as Chair and CEO of Outset Medical, Inc., shaping the company’s strategic direction since 2014 and assuming the role of Chair in 2022. Under Leslie’s leadership, Outset Medical launched the Tablo® hemodialysis system, achieving impressive market penetration in both acute and home dialysis sectors. She has overseen robust revenue growth and helped the company become a market leader in dialysis innovation—solidifying her position as the face of Outset Medical, Inc. CEO excellence.
Leslie holds her undergraduate degree from Northwestern University and an MBA from UC Berkeley’s Haas School of Business. Her prior leadership experience includes Executive in Residence at Warburg Pincus, Executive Vice President at Lutonix (acquired by CR Bard), Chief Business Officer at AccessClosure (Cardinal Health), Vice President of Marketing at FoxHollow Technologies (Covidien), and leadership roles at Cytyc Corporation, Pro-Duct Health, and Guidant Corporation, demonstrating broad expertise in medical device commercialization and company scaling.
Nabeel Ahmed has served as Chief Financial Officer since August 2021 (initially as interim CFO), optimizing Outset Medical, Inc.’s financial operations and leading initiatives that strengthened profitability and unlocked access to capital. Nabeel has driven improvements in gross margin, implemented effective cost management strategies, and orchestrated public offerings and debt facilities, further cementing his impact as a pivotal Outset Medical, Inc. management team member.
Nabeel received his Bachelor of Commerce from Laurentian University and an MBA from The Wharton School, University of Pennsylvania. Before joining Outset Medical, Inc., he was Vice President, Finance at 8D78, Inc. and Vocera Communications, CFO at Wanderful Media and MarketTools, and held leadership roles at Ernst & Young LLP and eBay.
Renee Gaeta was appointed Chief Financial Officer in June 2025, bringing a focus on scaling Outset Medical, Inc.’s financial strategy, optimizing global budgeting, forecasting, investor relations, and supporting R&D investments. She is spearheading initiatives to drive growth, streamline operations, and coordinate the company’s expansion into new international markets, reinforcing the strength of the Outset Medical, Inc. executives bench.
Renee holds a BS from Loyola Marymount University, and most recently served as CFO at Eko Health and Shockwave Medical, as well as Board Director at Candel Therapeutics. Her experience also includes finance leadership roles at SeaSpine, MarketTools, and eBay.
Michael Aragon serves as Chief Medical Officer, guiding the company’s clinical strategy since September 2018. He leads initiatives expanding Outset Medical, Inc.’s home dialysis programs, and his clinical research has informed regulatory and adoption strategies for the Tablo system, establishing Outset Medical, Inc. leadership in both inpatient and home environments.
Michael is board certified in Internal Medicine and Nephrology, completed his medical training at UT Health Sciences Center in Houston, and holds a BA from Texas A&M University and MD from University of Texas Medical School. Previously, he was the founding partner and President of North Texas Kidney Consultants-DFW for 14 years, bolstering his clinical and administrative acumen.
Isaac Stockwell has been responsible for leading IT strategy at Outset Medical, Inc. since 2018. Isaac has implemented secure, enterprise-wide ERP and CRM systems, improved regulatory compliance, and delivered scalable analytics platforms—contributing to operational resiliency and data-driven decision-making within the Outset Medical, Inc. management team.
Isaac earned a BS from California State University, Chico and was previously IT Manager at Abbott and St. Jude Medical. He has advanced from Director to Senior Director of Information Technology since joining Outset Medical, Inc.
Marc Nash has overseen Outset Medical, Inc. operations and R&D since 2023. Marc implemented lean manufacturing processes, managed product innovation roadmaps, and expanded capacity to meet growing international demand, driving efficiency and support for next-gen home dialysis technology.
Marc holds a BA from Union College and previously served as GM of Outset Mexico, Vice President of Manufacturing, and Senior Director of Operations at Outset Medical, Inc., and in other manufacturing leadership roles in the medical device sector.
Jean-Olivier Racine assumed the role of Chief Technology Officer in 2024, leading integrated hardware and software engineering for the Tablo system. Jean-Olivier’s development of enhanced device connectivity and advanced data analytics aligns with the innovation-driven focus of Outset Medical, Inc. leadership.
He holds an MSc in Biomedical Engineering and was previously CTO at a medical technology startup, VP of Engineering at a healthcare software firm, and held senior engineering positions in medtech R&D.
Kulwant Sandhu joined Outset Medical, Inc. in 2022 as Vice President, Integrated Supply Chain. Kulwant developed reliable, end-to-end global supply chain processes, cut lead times by 20%, and implemented sophisticated S&OP planning—critical to Outset Medical, Inc. management team efficiency and resilience.
Kulwant holds a BS in Industrial Engineering. He was formerly Senior Supply Chain Manager at Abbott and led manufacturing operations at Stryker before joining Outset Medical, Inc.
Cristina Escalante, MBA has been Global Chief Operating Officer and CFO at Outset Medical, Inc. since 2021, overseeing regional expansions and harmonizing finance and operations across Europe and Asia. She drives operational excellence, regional expansion, and international financial strategy for the company.
Cristina holds an MBA from the University of Exeter, was Executive Director in Risk Management and Corporate Treasury at Goldman Sachs, and has experience in FP&A and corporate accounting.
Benjamin Kwon is the COO and co-founder of OutsetOps, leading go-to-market product strategy and customer success. Benjamin has scaled predictive revenue planning to 100+ enterprise clients and built integrations with Salesforce, powering business insights that align with the forward-looking mindset of Outset Medical, Inc. founders and executives.
Ben holds an MBA from Stanford Graduate School of Business. He was COO at LeadIQ, held product leadership at Anaplan, and was an early growth leader at Mavenlink.
Outset Medical, Inc. executives and management have established a structure integrating medical, operational, technological, and financial leadership. The company’s founders and experienced executives—spanning clinical, business, IT, supply chain, and R&D management—foster a culture of innovation and operational excellence, positioning Outset Medical, Inc. as a leader in the dynamic medical device and healthcare technology landscape. The Outset Medical, Inc. leadership team’s collective experience and alignment around next-generation dialysis solutions fuel ongoing growth and strategic expansion.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Outset Medical, Inc. leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.